(Bloomberg) -- An exodus from defensive plays made Swiss equities lag most developed markets this quarter, sending the number of outstanding bearish options to an eight-year high versus contracts betting on gains. A run into companies including Novartis AG and Roche Holding AG in the immediate aftermath of the Brexit vote pushed Swiss valuations to the highest since 2008 relative to their euro-area peers. “At a certain point you start taking a chance with other stocks -- there are just more opportunities out there,” said Ion-Marc Valahu, co-founder and fund manager at Clairinvest in Geneva.
To contact the reporter on this story: Roxana Zega in Zurich at rzega@bloomberg.net. To contact the editors responsible for this story: Cecile Vannucci at cvannucci1@bloomberg.net, Alan Soughley, Nancy Moran
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
